ADC Therapeutics to Present at Upcoming Investor Conferences
September 03 2024 - 7:15AM
ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader
and pioneer in the field of antibody drug conjugates (ADCs), today
announced participation in two investor conferences in September:
H.C. Wainwright 26th Annual Global Investment Conference
Date: September 9, 2024Presentation Time: 7:00 a.m. ETFormat:
Virtual Fireside Chat Speaker: Ameet Mallik, Chief Executive
Officer
10th Cantor Global Healthcare Conference 2024
Date: September 18, 2024 Presentation Time: 11:30-12:00 p.m.
ETFormat: Fireside Chat Speaker: Ameet Mallik, Chief Executive
Officer
Live webcasts of the presentations will be available via the
Events & Presentations page in the Investors section of ADC
Therapeutics’ website, ir.adctherapeutics.com. A replay of each
webcast will be available for approximately 30 days following each
event.
About ADC Therapeutics
ADC Therapeutics (NYSE: ADCT) is a commercial-stage global
leader and pioneer in the field of antibody drug conjugates (ADCs).
The Company is advancing its proprietary ADC technology to
transform the treatment paradigm for patients with hematologic
malignancies and solid tumors.
ADC Therapeutics’ CD19-directed ADC ZYNLONTA (loncastuximab
tesirine-lpyl) received accelerated approval by the FDA and
conditional approval from the European Commission for the treatment
of relapsed or refractory diffuse large B-cell lymphoma after two
or more lines of systemic therapy. ZYNLONTA is also in development
in combination with other agents and in earlier lines of therapy.
In addition to ZYNLONTA, ADC Therapeutics has multiple ADCs in
ongoing clinical and preclinical development.
ADC Therapeutics is based in Lausanne (Biopôle), Switzerland,
and has operations in London and New Jersey. For more information,
please visit the Company website at adctherapeutics.com and follow
us on LinkedIn.
ZYNLONTA® is a registered trademark of ADC Therapeutics SA.
CONTACTS:
InvestorsMarcy GrahamADC
TherapeuticsMarcy.Graham@adctherapeutics.com+1 650-667-6450
MediaNicole RileyADC
TherapeuticsNicole.Riley@adctherapeutics.com+1 862-926-9040
ADC Therapeutics (NYSE:ADCT)
Historical Stock Chart
From Aug 2024 to Sep 2024
ADC Therapeutics (NYSE:ADCT)
Historical Stock Chart
From Sep 2023 to Sep 2024